Saber S - Search Results

1

AKT-AMPKα-mTOR-dependent HIF-1α Activation is a New Therapeutic Target for Cancer Treatment: A Novel Approach to Repositioning the Antidiabetic Drug Sitagliptin for the Management of Hepatocellular Carcinoma.

Abd El-Fattah EE, Saber S, Youssef ME, Eissa H, El-Ahwany E, Amin NA, Alqarni M, Batiha GE, Obaidullah AJ, Kaddah MMY, Ahmed Gaafar AG, Mourad AAE, Mostafa-Hedeab G, Abdelhamid AM. Abd El-Fattah EE, et al. Among authors: saber s. Front Pharmacol. 2022 Jan 12;12:720173. doi: 10.3389/fphar.2021.720173. eCollection 2021. Front Pharmacol. 2022. PMID: 35095479 Free PMC article.

2

Renin-angiotensin system inhibition ameliorates CCl₄-induced liver fibrosis in mice through the inactivation of nuclear transcription factor kappa B.

Saber S, Mahmoud AAA, Helal NS, El-Ahwany E, Abdelghany RH. Saber S, et al. Can J Physiol Pharmacol. 2018 Jun;96(6):569-576. doi: 10.1139/cjpp-2017-0728. Epub 2018 Feb 9. Can J Physiol Pharmacol. 2018. PMID: 29425464

3

Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B.

Saber S, Mahmoud AAA, Goda R, Helal NS, El-Ahwany E, Abdelghany RH. Saber S, et al. Toxicol Lett. 2018 Oct 1;295:32-40. doi: 10.1016/j.toxlet.2018.05.036. Epub 2018 May 31. Toxicol Lett. 2018. PMID: 29859236

4

Liver Protective Effects of Renin-Angiotensin System Inhibition Have No Survival Benefits in Hepatocellular Carcinoma Induced By Repetitive Administration of Diethylnitrosamine in Mice.

Saber S, Mahmoud A, Helal N, El-Ahwany E, Abdelghany R. Saber S, et al. Open Access Maced J Med Sci. 2018 Jun 6;6(6):955-960. doi: 10.3889/oamjms.2018.167. eCollection 2018 Jun 20. Open Access Maced J Med Sci. 2018. PMID: 29983784 Free PMC article.

5

Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NFκB and Nrf-2/HO-1 signaling crosstalk.

Saber S, Khalil RM, Abdo WS, Nassif D, El-Ahwany E. Saber S, et al. Toxicol Appl Pharmacol. 2019 Feb 1;364:120-132. doi: 10.1016/j.taap.2018.12.020. Epub 2018 Dec 27. Toxicol Appl Pharmacol. 2019. PMID: 30594690

6

Novel complementary antitumour effects of celastrol and metformin by targeting IκBκB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesis.

Saber S, Ghanim AMH, El-Ahwany E, El-Kader EMA. Saber S, et al. Cancer Chemother Pharmacol. 2020 Feb;85(2):331-343. doi: 10.1007/s00280-020-04033-z. Epub 2020 Jan 27. Cancer Chemother Pharmacol. 2020. PMID: 31989218

7

Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling.

Khalil R, Shata A, Abd El-Kader EM, Sharaf H, Abdo WS, Amin NA, Saber S. Khalil R, et al. Among authors: saber s. Toxicol Appl Pharmacol. 2020 Nov 15;407:115246. doi: 10.1016/j.taap.2020.115246. Epub 2020 Sep 19. Toxicol Appl Pharmacol. 2020. PMID: 32956689

8

BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats.

Saber S, Youssef ME, Sharaf H, Amin NA, El-Shedody R, Aboutouk FH, El-Galeel YA, El-Hefnawy A, Shabaka D, Khalifa A, Saleh RA, Osama D, El-Zoghby G, Gobba NA. Saber S, et al. Life Sci. 2021 Apr 1;270:119123. doi: 10.1016/j.lfs.2021.119123. Epub 2021 Feb 3. Life Sci. 2021. PMID: 33548287

9

Novel Potent and Selective DPP-4 Inhibitors: Design, Synthesis and Molecular Docking Study of Dihydropyrimidine Phthalimide Hybrids.

Mourad AAE, Khodir AE, Saber S, Mourad MAE. Mourad AAE, et al. Among authors: saber s. Pharmaceuticals (Basel). 2021 Feb 11;14(2):144. doi: 10.3390/ph14020144. Pharmaceuticals (Basel). 2021. PMID: 33670273 Free PMC article.

10

A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition.

Saber S, Abd El-Fattah EE, Yahya G, Gobba NA, Maghmomeh AO, Khodir AE, Mourad AAE, Saad AS, Mohammed HG, Nouh NA, Shata A, Amin NA, Abou El-Rous M, Girgis S, El-Ahwany E, Khalaf EM, El-Kott AF, El-Baz AM. Saber S, et al. Pharmaceuticals (Basel). 2021 Apr 8;14(4):341. doi: 10.3390/ph14040341. Pharmaceuticals (Basel). 2021. PMID: 33917884 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters